XML 29 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Reporting (Tables)
6 Months Ended
Jun. 30, 2014
Segment Reporting [Abstract]  
Reconciliation of the Company's business segments to the consolidated financial statements
In millions
Pharmacy
Services
Segment(1)
 
Retail
Pharmacy
Segment
 
Corporate
Segment
 
Intersegment
Eliminations(2)
 
Consolidated
Totals
Three Months Ended
 
 
 
 
 
 
 
 
 
June 30, 2014:
 
 
 
 
 
 
 
 
 
Net revenues
$
21,836

 
$
16,871

 
$

 
$
(4,105
)
 
$
34,602

Gross profit
1,195

 
5,299

 

 
(170
)
 
6,324

Operating profit (loss)
878

 
1,705

 
(205
)
 
(170
)
 
2,208

June 30, 2013:
 

 
 

 
 

 
 

 
 

Net revenues
18,800

 
16,139

 

 
(3,691
)
 
31,248

Gross profit
963

 
5,005

 

 
(127
)
 
5,841

Operating profit (loss)
675

 
1,600

 
(176
)
 
(127
)
 
1,972

Six Months Ended
 

 
 

 
 

 
 

 
 

June 30, 2014:
 

 
 

 
 

 
 

 
 

Net revenues
42,031

 
33,351

 

 
(8,091
)
 
67,291

Gross profit
2,129

 
10,483

 

 
(346
)
 
12,266

Operating profit (loss)
1,518

 
3,455

 
(395
)
 
(346
)
 
4,232

June 30, 2013:
 

 
 

 
 

 
 

 
 

Net revenues
37,111

 
32,179

 

 
(7,291
)
 
61,999

Gross profit
1,731

 
9,952

 

 
(265
)
 
11,418

Operating profit (loss)
1,174

 
3,132

 
(375
)
 
(265
)
 
3,666

Total assets:
 

 
 

 
 

 
 

 
 

June 30, 2014
41,189

 
30,803

 
1,790

 
(1,189
)
 
72,593

December 31, 2013
38,343

 
30,191

 
4,420

 
(1,428
)
 
71,526

Goodwill:
 

 
 

 
 

 
 

 
 

June 30, 2014
21,233

 
6,893

 

 

 
28,126

December 31, 2013
19,658

 
6,884

 

 

 
26,542


(1)          Net revenues of the Pharmacy Services Segment include approximately $2.0 billion of retail co-payments for the three months ended both June 30, 2014 and 2013, as well as $4.2 billion of retail co-payments for the six months ended both June 30, 2014 and 2013.
(2)        Intersegment eliminations relate to two types of transactions: (i) Intersegment revenues that occur when Pharmacy Services Segment customers use Retail Pharmacy Segment stores to purchase covered products. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue on a stand-alone basis, and (ii) Intersegment revenues, gross profit and operating profit that occur when Pharmacy Services Segment customers, through the Company’s intersegment activities (such as the Maintenance Choice® program), elect to pick-up their maintenance prescriptions at Retail Pharmacy Segment stores instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue, gross profit and operating profit on a standalone basis. The following amounts are eliminated in consolidation in connection with the intersegment activity described in item (ii) above: net revenues of $1.2 billion and $1.1 billion for the three months ended June 30, 2014 and 2013, respectively, and $2.3 billion and $2.0 billion for the six months ended June 30, 2014 and 2013, respectively; and gross profit and operating profit of $170 million and $127 million for the three months ended June 30, 2014 and 2013, respectively, and $346 million and $265 million for the six months ended June 30, 2014 and 2013, respectively.